# Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic Bladder

> **NCT01716624** · PHASE3 · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 20 (estimated)

## Conditions studied

- Neurogenic Bladder

## Interventions

- **DRUG:** Oxybutynin
- **DRUG:** Botulinum Toxin A injection

## Key facts

- **NCT ID:** NCT01716624
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-03
- **Final completion:** 2012-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2012-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01716624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01716624, "Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic Bladder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01716624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*